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Summary 
Leishmania major promastigotes were found to avoid activation of mouse bone marrow-derived 
macrophages (BMMo) in vitro for production of cytokines that are typically induced during 
infection with other intracellular pathogens. Coexposure of BMMo to the parasite and other 
microbial stimuli resulted in complete inhibition ofinterleukin (IL) 12 (p40) mRNA induction 
and IL-12 release. In contrast, mRNA and protein levels for IL-lot, IL-113, tumor necrosis fac- 
tor (TNF) ci, and inducible NO synthase (iNOS) were only partially reduced, and signals for 
IL-10 and monocyte chemoattractant protein (MCP-1/JE) were enhanced. The parasite could 
provide a detectable trigger for TNF-cx and iNOS in BMMo primed with interferon (IFN) y, 
but still  failed to induce IL-12. Thus IL-12 induction is selectively impaired after infection, 
whereas activation pathways for other monokine responses remain relatively intact.  Selective 
and complete inhibition of IL-12(p40) induction was  observed using BMMo from either ge- 
netically susceptible or resistant mouse strains,  as well as IL-10 knockout mice, and was ob- 
tained using promastigotes from cutaneous, visceral,  and lipophosphoglycan -deficient strains of 
Leishmania. The impaired production of the major physiologic inducer oflFN-y is suggested to 
underlie the relatively prolonged interval of parasite intracellular survival and replication that is 
typically associate with leishmanial infections, including those producing self-limiting disease. 
eishmania  sp.  are  obligate  intracellular  protozoa  that 
colonize macrophages in the vertebrate host, and their 
control requires the induction of immune responses capa- 
ble of activating macrophages to a microbicidal state.  The 
most potent cytokine for the  induction of leishmanicidal 
activity in macrophages is IFN-y (1, 2). The sustained pro- 
duction of IFN-y in response to infection is commonly as- 
sociated with the development of specific Thl  and CD8 + 
T  cell responses, whereas NK cells have been identified as 
an important,  though more  transient source of this  cyto- 
kine  (reviewed in  reference 3).  Parasites  that  are  able  to 
compromise the induction  or function of IFN-y are un- 
doubtedly favored for transmission since organisms able to 
attain high parasitemias and/or to persist in the vertebrate 
host will be more likely to  encounter their phlebotomine 
vectors. 
Considering the central role ofmacrophages in the initi- 
ation as well as effector functions of the immune response, 
infection of these cells might impair their ability to provide 
the appropriate regulatory cytokines for enhanced produc- 
tion of IFN-% Recent studies indicate that IL-12 plays an 
important role in  potentiating cell-mediated immune  re- 
sponses during leishmanial infection. IL-12 is a heterodimeric 
cytokine produced primarily by monocytes, macrophages, 
and B  cells,  that stimulates growth  of Thl  and NK lym- 
phocytes and induces synthesis oflFN-y by these cells (4-6). 
In models of murine leishmaniasis,  treatment of susceptible 
BALB/c mice with rlL-12 rendered these animals  resistant 
to L.  major by upregulating IFN-~/ and simultaneously in- 
hibiting Th2 cytokine production (7, 8).  In vivo adminis- 
tration of IL-12 in mice also potentiated the efficacy of a 
killed vaccine for L.  major (9) and provided effective ther- 
apy for an established systemic infection with L.  donovani 
(10).  In vitro and in vivo experiments have demonstrated 
the crucial role of IL-12 in initiating and establishing both 
innate  immunity and  T  cell-mediated resistance to  other 
intracellular pathogens, including Toxoplasma gondii,  Listeria 
monocytogenes, and Mycobacterium  tuberculosis (11-14). Expo- 
sure ofmacrophages to these organisms results in strong in- 
duction oflL-12 in vitro. In contrast, L.  major fails to elicit 
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vitro, (15-17),  and this has been suggested as an important 
strategy to delay the onset of strong IFN-~/production and 
macrophage activation during the early stages of  infection (15). 
In  the  present  studies,  we  ask  whether  cytokine  re- 
sponses by macrophages are  induced,  avoided, or actively 
impaired during in vitro infection with metacyclic promas- 
tigotes of different strains of Leishmania.  Our approach was 
to  follow the kinetics of cytokine responses by bone mar- 
row-derived macrophages (BMMo) 1 exposed to Leishmania 
promastigotes  alone,  or  in  combination  with  microbial 
stimuli  known  to  activate  cytokine  gene  expression  by 
these  cells.  The  responses  examined  included  the  proin- 
flammatory  cytokines  IL-loL,  IL-l[3,  and  TNF-oL;  the 
monocyte  chemoattractant  protein  (MCP-1/JE);  inducible 
NO  synthase  (iNOS);  and  the  immunomodulatory  cyto- 
kines IL-12 and IL-10. Our findings support the hypothesis 
that in contrast to other intracellular pathogens,  Leishmania 
promastigotes  fail  to  induce  strong  monokine  responses 
generally, but that only the absence of IL-12(p40)  mRNA 
expression and IL-12 release is due to an active and power- 
ful inhibition of its induction. The selective impairment oflL- 
12  induction  might  underlie  the  early  progression  but 
eventual control that is characteristic of leishmanial infec- 
tions in the vertebrate host. 
Materials and Methods 
Macrophages.  Female  BALB/c,  C3H/HeN,  and  C57BL/6N 
036), mice  8-12-wk  old,  were  obtained from  the  Division of 
Cancer Treatment,  National Cancer  Institute (Frederick, MD). 
The  B6  IL-10-deficient (knockout)  mice  have been previously 
characterized (18). BMMo were recovered following a previously 
published protocol  (19),  with  minor modifications. Briefly, fe- 
murs were flushed with HBSS containing 25 mM Hepes and 50 
I~g/ml  gentamycin  sulfate,  using  a  27-in  gauge  needle.  Bone 
marrow ceils were washed once and resuspended in DMEM sup- 
plemented with  10%  HI-FCS, 30%  L929  cefl-conditioned me- 
dium  (source of M-CSF),  100  mM  sodium pyruvate, 0.1  mM 
NEAA,  2  mM  g-glutamine,  100  U/m1  penicillin,  100  mg/ml 
streptomycin,  and  50  ~g/ml  gentamycin.  Differentiated  MO 
were allowed to adhere overnight in 75 cm  2 culture flasks. Non- 
adherent cells were removed and plated (3 plates/mouse) in 3.5 
cm polystyrene culture-treated petri dishes and incubated for 7 d 
at 37~  and  5%  CO2.  1  d  before infection, cells  were  washed 
twice and replenished with complete medium without L929 su- 
pernatants. 
Parasites.  L.  major  clone  V1  (MHOM/IL/80/Friedlin)  and 
L.  donovani 1S strain (MHOM/SD/001S-2D)  and its derived li- 
pophosphoglycan (LPG)-deficient mutant, R2D2,  (20) were cul- 
tured in 199 medium supplemented with 20% HI-FCS, 100 U/ml 
penicillin, 100 Ixg/ml streptomycin, 2 mM L-glutamine, 40 mM 
Hepes, 0.1  mM adenine (in 50 m/Vl Hepes), 5 btg/ml heroin (in 
50% triethanolamine), and 1 ~g/ml 6-biotin (in 95% EtOH). In- 
~Abbreviations used in  this paper: BMMo,  bone  marrow-derived  macro- 
phages; HPRT, hypoxanthine-guanine phosphoribosyl transferase;  iNOS, 
inducible  nitric  oxide  synthase; LPG, lipophosphoglycan; MCP-I/JE, 
monocyte chemoattractant protein; Mtb, Mycobacterium tuberculosis; PKC, 
protein kinase C; STAg,  soluble antigen from Toxoplasma  gondii. 
fective-stage promastigotes (metacyclics) of L.  major were isolated 
from stationary cultures (5-6 d old) by their lack of agglutination 
by peanut agglutinin (PNA) (21).  The L.  donovani  promastigotes 
were obatined from unselected stationary cultures. Before infec- 
tion, promastigotes were opsonized with 5% C5-deficient serum 
obtained from  B10.D2/OsNj  mice,  by incubation at  37~  for 
30 rain. 
Macrophage Infections and Activation.  For determination of cy- 
tokine responses in infected macrophages, parasites were used at a 
parasite/macrophage ratio of 20:1. LPS (Sigma Chemical Co., St. 
Louis, MO) was used in all the experiments at a concentration of 
10  ng/ml.  Recombinant mouse  IFN-~ was used at  100  U/ml. 
Heat  killed M.  tuberculosis was  kindly supplied by Drs.  Patrick 
Brennan  and  Andrea  Cooper  (Colorado  State University,  Fort 
Collins, CO)  and used at three different concentrations:  1,000, 
100, and 10 bacteria/macrophage). Soluble antigen from T. gondii 
(STAg) was prepared as described (22) and used at 10 ~g/ml. The 
stimuli  were  either  added  to  macrophages  alone,  or  simulta- 
neously with parasites for 2, 6, and 8 h before harvesting superna- 
tants or addition of RNAzol for extraction ofmRNA. 
mRNA  Detection  by RT-PCR.  mRNA  detection for  the  cy- 
tokines IL-llx, IL-113, TNF-o~,  IL-10, and IL-12(p40), the [3-che- 
mokine  MCP-1/JE,  iNOS,  as  well  as  a  housekeeping  gene, 
hypoxanthine-guanine  phosphoribosyltransferase  (HPRT),  were 
performed using a semiquantitative RT-PCR method previously 
described (23), with minor modifications. Briefly, at various times 
after incubation with parasites  or stimuli, RNAzol was added di- 
rectly to  the petri dishes,  and RNA extracted from the BMMo 
following the  manufacturer's  recommendations.  1  Ftg of RNA 
was  reverse transcribed using Moloney murine  leukemia virus 
reverse transcriptase (GIBCO BRL, Gaithersburg, MD). Samples 
were denatured at 70~  for 5 min before the addition of the en- 
zyme and were then incubated 1 h at 60~  and 5 rain at 90~  to 
inactivate the enzyme. After cooling on ice for 3  rain,  samples 
were diluted in distilled water to a final volume of 200  p~l (1:8) 
and stored at -20~  10 ~1 of this solution was used for amplifica- 
tion in a semiquantitative PCR with Taq I Polymerase (Promega 
Corp., Madison, WI). Samples were incubated for 3 min at 95~ 
and were then amplified with an experimentally determined opti- 
mal temperature cycle number  of (94~  for  1 min,  54~  for  1 
rain,  and 72~  for 2  min) for each cytokine mRNA.  24  cycles 
were  used  for HPRT,  IL-lo~,  IL-I~,  TNF-~x,  and JE;  35  for 
iNOS; 40 for IL-12(p40); and 30 cycles for IL-10. PCR products 
were Southern blotted, transferred to Hybond  + membranes (Am- 
ersham Corp., Arlington Heights, IL), and probed with cytokine- 
specific fluorescein-labeled  oligonucleotides. The enhanced chemi- 
luminescent (ECL) detection system (Amersham Corp.) was used 
for detection, exposing the membranes to byperfilm (Amersham 
Corp.)  at room temperature. The signals were analyzed using a 
densitometrical optical scanner  (model 600ZS;  Microteck, Tor- 
rance,  CA)  and  Image  software  (National Institutes of Health, 
Bethesda, MD). Results were expressed as fold increase over con- 
trol, considering the control value as one unit. 
The primers and probes used for amplification and detection 
were as described for IL-hx, IL-113, and TNF-~x (23); for IL-10 
and HPRT (24); for iNOS (22) and IL-12(p40)  (25); and forJE (26): 
HPRT: 5'-GTTGGATACAGGCCAAGACTTTGTTG; 3'-GAT- 
TCAACTTGCGCTCA-TCTTAGGC; probe GTTGTTGGAT- 
TGCCCTTGAC;  IL-loc  5'-TGAGATTTTTAGAGTAACAGG; 
3'-GGAAGATTGTCAAGAAGAGACGG;  probe  CCAGAT- 
CAGCACCTTACACC;  IL-113: 5'-GGGATGATGATGATA- 
ACCTG; 3'-TTGTCGTTGCTTGGTTCTCCT;  probe CAG- 
CTGCACTACAGGCTCCG;  TNF-~x:  5'-CTCCAGCTGGA- 
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GTG; probe CCCGACTACGTGCTCCTCACC; iNOS: 5'-CTG- 
GAGGAGCTCCTGCCTCATG;  3'-GCAGCATCCCCTCT- 
GATGGTG; probe CTGGATGAGCTCATCTTTGCC;  IL-12 
p40:  5'-CGTGCTCATGGCTGGTGCAAAG;  3'-CTTCAT- 
CTGCAAGTTCTTGGGC;  probe  TCTGTCTGCAGAGAA- 
GGTCACA;  IL-10:  5'-CGGGAAGACAATAACTG; 3'-CAT- 
TTCCGATAA.GGCTTGG;  probe  GGACTGCCTTCAGCC- 
AGGTGAAGACTTT; JE:  5'-TCAGCCAGATGCAGTTAACG; 
3'-CAAGAAGGAATGGGTCCAGA;  probe TCACCAGCAA- 
GATGATCCCAATGAG. 
Cytokine Detection Assays.  TNF-ot  was  determined by mea- 
suring  the  cytotoxicity to  TNF-sensitive L929  cells of macro- 
phage supematants recovered 6 h after infection and/or treatment 
(25).  Murine  (Mu) rTNF-ot was used as standard. IL-12 was as- 
sayed in  6-h  supernatants  by a  two-site RIA.  Briefly,  96-well 
plates were  coated overnight with  5  p~g/ml  C15.1.2  Ab in so- 
dium carbonate/bicarbonate buffer (pH 9.5). Plates were washed 
three  times with  PBS/0.05%  Tween  20.  Standard and  samples 
were added to the plates, incubated overnight, washed again with 
PBS/Tween and incubated for 6 h with 12SI-labeled C15.6.7 Ab. 
Bound radioactivity was assessed by scintillation counting and the 
amount oflL-12 calculated by reference to a standard curve gen- 
erated using rMulL-12 (Genetics Institute, Cambridge, MA). IL-1 
was measured as described (27) using the IL-let/[3-dependent cell 
line T1165.17, obtained from Dr. A. Glasebrook (Eli Lilly, India- 
napolis, IN)  and Dr.  Richard Titus  (Colorado State University, 
Ft. Collins, CO). The cells were maintained in DMEM plus 5% 
FCS  supplemented  with  human  rlL-lot  (R&D  Systems,  Inc., 
Minneapolis, MN). Cells were plated at 5,000 per well in dupli- 
cate wells in 96-well flat bottom plates and test supernatant was 
added to  a  final volume  of 200  ~1.  After a  42-h  incubation at 
37~  5%  CO2,  the  plates  were  pulsed  for  6  h  with  1  p,  Ci 
methyl-[3H]thymidine (5 Ci/mmol) (Amersham Corp.). Prolifer- 
ation was determined by scintillation counting,  and levels were 
calculated  by  reference  to  a  standard  curve  constructed  with 
rMulL-lot. 
Results 
Kinetics  of  Cytokine  mRNA  Expression  in  BMMo from 
BALB/c Mice Stimulated with LPS,  Mtb, or L.  major Promas- 
tigotes.  The  kinetics  of mtkNA  expression  for  TNF-ot, 
IL-lot,  IL-1]3,  IL-12(p40),  MCP-1/JE,  IL-10,  and  iNOS 
after  exposure  to  either  LPS,  Mtb,  or  serum-opsonized 
L.  major metacyclic promastigotes, are shown in Fig. 1, ex- 
pressed as fold increase over untreated  control.  Both LPS 
and Mtb induced strong mRNA  expression for each of the 
genes  analyzed. The  peak signal for each cytokine was al- 
ways  greater  in  response  to  Mtb,  except  IL-12(p40),  for 
which  the  LPS-  and  Mtb-induced  signals  were  roughly 
equivalent. Whereas positive signals were  seen by 2  h,  in 
each case the peak signals were seen at 6  h  after treatment, 
with  the  exception  of IL-I~  and  IL-10,  which  displayed 
equivalent  or  slightly stronger  signals  at  the  earlier  time 
point. By 18 h, transcript levels of each of the genes had re- 
turned to just above baseline, again with the exception of 
IL-113, which maintained strong expression at each of the 
time points studied.  In contrast to LPS and Mtb, L.  major 
promastigotes seemed to largely avoid activation of BALB/c 
BMMo, despite their efficient attachment to and uptake by 
these  cells  (more  than  90%  of cells  infected,  more  than 
three promastigotes per cell). No positive signals were de- 
tected for either IL-lot, IL-1[3, IL-12(p40), or iNOS at any 
of the time points studied. A  weak signal for TNF-ot, and 
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Figure  1.  Kinetics of mRNA 
expression  in  BMMo  from 
BALB/c  mice  exposed  to  LPS 
(open squares), high  dose-killed 
Mtb  (closed squares), or L.  major 
metacyclic promastigotes  (closed 
triangles), mRNA levels are ex- 
pressed  relative  to  levels  in 
untreated  control  cells at  each 
time  point  (given an  arbitrary 
value of 1). 
517  Carrera et al. Figure 2.  Effect  of L.  major metacyclic promastigotes 
on  LPS- and  Mtb-induced  expression  of  cytokine 
mRNA. BMMo from BALB/c mice were exposed to L. 
major metacyclics (Lm), LPS, or killed Mtb at 1,000, 10(t, 
and 10 bacteria/macrophage (Mtb 1, 2, and 3), added ei- 
ther alone or at the same time, as indicated. Semiquanti- 
tative RT PCR was done on RNA from each sample, 
and the products were visualized after Southern transfer. 
mRNA levels obtained after 6 h of incubation are shown 
for each of the cytokines, except for IL-10, for which the 
2-h time point is shown. Results are representative of six 
separate experiments. 
weak but consistent signals for IL-10 andJE were observed 
at 2  h, declining to baseline by 6  h. These signals were no 
stronger when examined at 1 and 24 h  (data not shown). 
Effect of L.  major Infection on LPS- and Mtb-induced BMMo 
Activation.  The  effect  of leishmanial  infection  on  either 
LPS- or Mtb-induced  mRNA  expression in BMMo from 
BALB/c mice was examined in separate experiments at 6 h 
after treatment  for IL-lcx, IL-1]3, TNF-ot, iNOS,  and  IL- 
12(p40),  and at 2 h  for IL-10. Again, the parasite alone in- 
duced  no  detectable  proinflammatory  cytokine  mRNA, 
except  for  very  weak  expression  of TNF-er  (Fig.  2).  In 
contrast, parasite activation of IL-10 message was relatively 
strong in  these  experiments.  LPS and Mtb,  at  each  of the 
three  doses  tested,  induced  strong  expression  of all  cyto- 
kine  genes,  with  the  exception  of IL-10, which was  only 
weakly expressed  after 2  h  in response to LPS.  The  effect 
of the parasite on these responses was a partial inhibition of 
IL-l(x,  IL-1[3, TNF-(x,  and  iNOS,  a  strong inhibition  of 
IL-12(p40), and potentiation  of lL-10. The IL-12(p40) re- 
sponse  to  LPS  was  completely  inhibited,  as  was  the  IL- 
12(p40)  response to the lowest concentration of Mtb.  The 
opposite  effects that  the  promastigotes  had  on  IL-12(p40) 
and IL-10 mRNA induction are more quantitatively repre- 
sented in Fig.  3, which,  after normalizing for input RNA, 
confirms  the  virtually  complete  inhibition  of  the  IL- 
12(p40)  response  to LPS and lower doses  of Mtb,  and re- 
veals in addition a strong inhibition of the response to even 
the  highest  concentration  of Mtb.  The  upregulation  of 
IL-10 is significant at the lower doses of Mtb. 
L.  major  Promastigotes Evade  Cellular  Activation  of BMMo 
from  Genetically Resistant  As  Well As  Susceptible Mouse  Strains. 
The  differential  effects  that  the  parasite  has  on  cytokines 
known  to  regulate  the  development  of distinct  CD4 +  T 
cell subsets  suggested  a possible  mechanism to  explain  the 
preferential  activation of Th2  ceils that occurs in response 
to L.  major infection in susceptible  BALB/c mice.  To ex- 
plore this possibility further,  BMMo from BALB/c as well 
as  genetically resistant  B6  and  C3H  mice  were  compared 
for their responses to the parasite  alone  or in  combination 
with  LPS  or  Mtb.  Infection  with  L.  major  promastigotes 
failed to induce expression ofIL-lcl, TNF-ix, or IL-12(p40) 
in  cells  from  either  susceptible  or  resistant  mice  (Fig.  4). 
IL-10 mRNA  also was not detected,  although in these ex- 
periments only the 6-h time point was analyzed. Low levels of 
parasite-induced  transcripts  for JE  were  detectable  in  cells 
from BALB/c and B6 mice.  The  effects of the parasite  on 
LPS- and  Mtb-induced  responses  were  also  similar  in  the 
three mouse strains.  Slight inhibition of IL-l~x and TNF-o~ 
was accompanied by complete inhibition of both LPS- and 
Mtb-induced  IL-12(p40)  expression  in  all  three  mouse 
strains.  Upregulation  of IL-10 and JE  also occurred in the 
three mouse strains. 
The levels ofIL-lci, TNF-or  and IL-12 contained in the 
BMMo  culture  supernatants  were  also  determined  for the 
three  mouse  strains  (Table  1).  TNF-oL  and  IL-12  were 
measured in  6-h supernatants  from the  same  cells  used for 
mRNA  analyses. Reliable assay of IL-1 required longer in- 
cubation,  and was determined  from a  separate  experiment 
in which supernatants  were harvested at  18 h. The protein 
levels  closely  reflected  the  pattern  of mRNA  expression 
determined by RT-PCR.  LPS and Mtb elicited good pro- 
duction of the three cytokines by cells from all three mouse 
strains.  These cytokines were not detectable in supernatants 
from the cells  exposed to L.  major promastigotes alone, save 
for the  relatively high  levels  of IL-lcx/[3 produced by the 
infected  cells  from  C3H  mice.  Furthermore,  the  parasite 
completely inhibited  (to  background levels)  the  LPS- and 
Mtb-induced  IL-12  production  by  cells  from  all  three 
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mouse strains. In contrast, TNF-o~ production was only re- 
duced by half or not at all, and IL-1  production was  actu- 
ally enhanced, again with comparable effects observed in all 
three mouse strains. Thus the selective effects that the para- 
site  has  on  IL-12(p40)  gene  expression  and  production 
seem not to be related to the long-term outcome of infec- 
tion in these mouse strains. 
Leishmania  Promastigotes Evade  Triggering IL-I2 Production 
in BMMo Primed with IFN-T.  Macrophages  are  consid- 
ered fully activated when they receive both "priming" and 
"triggering"  stimuli,  which  in experimental  systems  typi- 
cally have been provided by IFN-y  and LPS,  respectively 
(28).  If the  parasite's inability to  activate  macrophages  for 
cytokine expression were due to defects confined largely to 
macrophage  priming,  then  provision  of this  signal  might 
reveal a  triggering stimulus associated with infection. This 
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Figure  4.  Effect of  L.  major 
metacyclic promastigotes on LPS- 
and  Mtb-  (100 bacteria~macro- 
phage) induced expression of cyto- 
kine  mRNA  by  BMMo  from 
BALB/c, C3H/HeN, and C57BL/6 
mice. Cells  were harvested  for RNA 
at 6 h. Dashes indicate samples for 
which no data was obtained.  Re- 
sults are representative of two ex- 
periments. Table  1.  Effect  of L.  major  Metacyclic Promastigotes on LPS- and Mtb-induced  Cytokine Release by BMMo  from Susceptible 
and Resistant Mice 
TNF-~*  IL-lod~  IL-12" 
C57BL/6  C3H  BALB/c  C57BL/6  C3H  BALB/c  C57BL/6  C3H  BALB/c 
U/ml  U/ml  pg/ml 
control  0  0  0  6  0  0  135  141  130 
LPS  0  1,920  1,920  230  160  3l  1,306  1,406  996 
Lm  0  0  0  0  210  0  t45  139  171 
Lm/LPS  480  960  960  1,062  382  78  187  186  191 
Mtb 1  480  1,920  1,920  ND  ND  ND  710  531  854 
Lm/Mtb 1  480  960  1,920  ND  ND  ND  196  160  l 81 
Mtb 2  480  960  1,920  400  30  52  1,109  724  1,039 
Lm/Mtb 2  480  960  960  1,765  140  179  154  130  190 
* 6-h supernatants. 
* 18-h supernatants. 
possibility was  investigated in  BMMo  from  B6  mice  ex- 
posed simultaneously to IFN-~ and various microbial stim- 
uli.  Levels  of mRNA  were  determined  at  6  h,  and  are 
shown  in  Fig.  5  for  TNF-ot,  iNOS,  and  'IL-12,  each  of 
which  has  been  shown  to  be  upregulated  by  IFN-~/  (14, 
22,  29).  Costimulation  with  IFN-',/  increased  signals  for 
TNF-ix,  iNOS,  and  especially IL-12(p40)  in  response  to 
LPS, Mtb,  and STAg.  Costimulation with IFN-y also up- 
regulated mRNA  expression for TNF-ot and iNOS in cells 
infected with L.  major,  indicating that at least for some re- 
sponses,  the  parasite can provide a  measurable stimulus so 
long as the cells are adequately primed. In contrast, priming 
with  IFN-y had  no  effect  on  the  IL-12(p40)  response  to 
the  parasite,  which  remained  undetectable.  The  protein 
data for this experiment is shown in Table 2. Priming with 
IFN-2r  increased IL-12 production induced by LPS,  Mtb, 
and STAg by approximately twofold. The  IL-12 produced 
in  response  to  L.  major  promastigotes  remained  at  back- 
ground levels even in the presence of IFN-'y. Preexposure 
of the BMMo  to  IFN-y for  18  h  before as well as during 
infection still failed to induce IL-12 (data not shown).  The 
ability of IFN-3, to upregulate TNF-ot production was ap- 
parent only for the response to Mtb,  although the biologi- 
cal  assay  failed  to  detect  TNF-tx  released  in  response  to 
those stimuli for which the mRNA  signals were weak. 
The Downregulation  of lL-12  Induction  by L.  major Promas- 
tigotes Is Not IL-IO Dependent.  IL-10  was  originally  de- 
scribed as a factor produced by Th2  cells that inhibited the 
synthesis of cytokines by Thl  cells (30).  It has  since been 
shown  to be produced by other cell types, including Ly-1 
B cells, mast cells, and macrophages, and its effects on IFN-y 
production have  been shown  to  be through  an  inhibition 
of macrophage accessory cell function rather than  a  direct 
interaction  with  IFN-',/-producing  cells  (31).  IL-10  has 
been  found  to  inhibit the  production  of proinflammatory 
Figure  5.  Induction  of cytokine mRNA in BMMo  from C57BL/6 
mice exposed to L.  major  metacyclic promastigotes, Mtb (100 bacteria/ 
macrophage), or soluble antigen from T. gondii (STAg), during priming 
with IFN-"/. RNA was harvested for RT-PCR 6 h after treatment. Re- 
sults are representative of two experiments. 
520  Inhibition oflL-12 Induction by Leishmania Table 2.  Effect  of Priming with IFN-T on Cytokine Release by BMMo  fiom C57B1/6 Mice Exposed to L. major Metacydic Promastigotes 
and other Microbial Stimuli 
Media  IFN-'y  LPS  IFN-',//LPS  Lm  IFN-',//Lm  Mtb  IFN-',//Mtb  STAg  IFN-'y/STAg 
IL-12 (pg/ml)  172  132  4,079  8,940  259  171  2,055  3,733  289  594 
TNF-c~ (U/ml)  0  0  240  240  0  0  480  960  0  0 
cytokines  by macrophages,  including  TNF-tx,  IL-1,  IL-6, 
and IL-12 (32). As IL-10 mRNA  expression was stimulated 
early in  infection  (2  h)  by L.  major promastigotes,  and  its 
induction  by LPS or Mtb was also upregulated by the para- 
site,  the possibility that IL-10 might be responsible for the 
downregulation  of IL-12 synthesis during infection was as- 
sessed by analysis oflL-12(p40)  mR.NA induced in BMMo 
from IL-10 knockout  C57BL/6  mice  (Fig.  6).  The lack of 
detectable  IL-10  transcripts  in  the  activated  cells  from  the 
knockout mice is consistent with the fact that the 5' primer 
sequence  used  to  amplify  IL-10  cDNA  binds  within  the 
first  exon,  which  has  been  replaced  by a  neomycin  gene 
in the knockout  mice  (18).  In both the knockouts  and the 
wild-type  controls,  no  IL-12(p40)  mRNA  was  seen  in 
response to the parasite alone, and in both strains the LPS- 
and  Mth-induced  expression  of the  gene  was  strongly in- 
hibited by the parasite (Fig.  6). The apparent greater inten- 
sity  of  the  residual  IL-12(p40)  signals  observed  in  the 
knockout  cells was found to be comparably reduced  when 
normalized and expressed as fold increase over control. The 
lack  of any difference  between  the  strains  is reinforced by 
the  IL-12 levels in the  culture  supernatants.  For the  wild- 
type  cells,  LPS-  and  Mtb-induced  IL-12  production  was 
reduced  by the  parasite  from  2,892  and  1,413  pg/ml,  re- 
spectively, to 263  and 202 pg/ml.  However,  for the IL-10 
knockout  cells,  the  values  for  IL-12  were  reduced  from 
3,982  and 2,300 pg/ml to  165 and 97 pg/ml. 
The  Ability  of Promastigotes  to  Inhibit  IL-12  Activation  Is 
Not  Dependent  on  Expression  of the  Abundant  Surface Lipo- 
phosphoglycan.  LPG is the major surface glycoconjugate of 
Leishmania  promastigotes  and  has  been  implicated  in  the 
downregulation  of protein kinase C  (PKC)-mediated signal 
transduction  in  macrophages  (33).  To  determine  whether 
LPG plays a role in the inhibition  of activation signals lead- 
ing to IL-12(p40) expression, the Mtb-induced  mtLNA re- 
sponses  in  BMMo  from BALB/c  mice  were  examined  in 
the presence  of stationary phase  promastigotes  of L.  major, 
L.  donovani,  and  an  LPG-deficient  mutant  of L.  donavani, 
termed  P,2D2.  The  effects  of these  parasites  on  cytokine 
gene expression were similar in each case  (Fig.  7).  The re- 
sponses  induced  by the  parasites  themselves  were  negligi- 
ble,  save for the  low  expression  of TNF-ot.  Their inhibi- 
tory  effects  on  Mtb-induced  IL-1,  TNF-oL,  and  iNOS 
expression were slight in each case (the absence of an iNOS 
signal was not observed in a subsequent experiment), whereas 
each was able to completely inhibit expression oflL-12(p40). 
Finally,  each  strain was  able to significantly upregulate  the 
IL-10 response.  Thus,  the requirement  for LPG in the dif- 
ferential  effects on  cytokine  gene  expression  can  be  ruled 
out,  although  the  data  do  not  preclude  a  requirement  for 
glycolipids  structurally  related  to  LPG  which  are  still  ex- 
pressed by the R.2D2 mutant. 
Figure  6.  Effect  of L.  major metacyclic promastigotes on  LPS- and 
Mtb- (100 bacteria/macrophage) induced expression of IL-12 and IL-10 
mILNA by BMMo from wild-type C57BL/6 and IL-10 knockout mice. 
RNA was harvested for kT-PCP, 6 h after treatment. The signals ex- 
pressed as fold increase are shown for IL-12 only (solid bars, IL-IO knock- 
outs; hatched bars, wild-type). Results are representative of three  experi- 
ments. 
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Discussion 
Cells of the macrophage lineage play a pivotal role in the 
development  of immune  responses  to  microorganisms,  in 
part  through  the  processing  of microbial  antigens  for pre- 
sentation  to T  cells,  through  the  expression  of cell surface 
costimulatory molecules,  and through  the release of immu- 
noregulatory  cytokines.  The  ability  of  infected  macro- Figure 7.  Effect  of stationary phase promastigotes  of L. major  (Lm), L. 
donovani (Ld), or the LPG-deficient  L. donovani mutant (R2D2) on LPS- 
and  Mtb-  (100 bacteria/macrophage) induced expression of cytokine 
mRNA by BMMo from BALB/c mice. P,.NA was harvested for RT- 
PCP,. 6 h after  treatment. 
phages  to  present  leishmanial  antigens  to  T  cells  and  to 
drive their activation is well supported (34-36). The present 
data argue that infected macrophages will drive early T  cell 
activation  in  the  absence  of IL-12,  thereby  avoiding  the 
major physiologic inducer for Thl  development, elevated 
production  of IFN-% and activation of macrophages to  a 
microbicidal state. The findings are essentially in agreement 
with those of R,  einer et al.  (15),  who proposed that Leish- 
mania  promastigotes  avoid initiating  activation  signals  for 
inflammatory  and  immunodulatory  cytokines  generally, 
and IL-12 in particular, and in this way the survival of the 
parasite  in  the  vertebrate  host  is  prolonged.  The  present 
studies  extend  these  observations  by  demonstrating  that 
whereas the attachment to and entry of Leishmania promas- 
tigotes  into  macrophages proceeds  in  a  remarkably silent 
manner,  of the various cytokine responses examined,  only 
the  induction  of IL-12(p40) was found to be actively im- 
paired. 
Infection  of  BMMo  with  serum-opsonized  L.  major 
metacyclic promastigotes failed to induce  detectable levels 
of mRNA for most of the  cytokine  genes studied.  Weak 
but positive signals  for IL-10 and JE were consistently ob- 
served,  especially when  the  response was  examined  early. 
Infection of BMMo  during  exposure  to  microbial stimuli 
known to initiate strong activation signals  resulted in three 
general effects:  (a) strong, and in most cases, complete inhi- 
bition of IL-12(p40) mRNA and protein synthesis; (b) par- 
tial,  and in most cases,  weak inhibition  of mP,.NA and/or 
protein for IL-tx, IL-lJ3, TNF-~x, and iNOS; and (c) upreg- 
ulation  of mIkNA for IL-10 and MCP-1/JE.  These  out- 
comes suggest that IL-12 production is tightly regulated by 
an  activation pathway(s)  that  is  selectively and  efficiently 
compromised  by  Leishmania  promastigotes  during  infec- 
tion.  The  involvement  of  several  alternative  induction 
pathways for TNF-0t and IL-~ (28,  37, 38)  suggests a basis 
for the partial inhibition of these cytokines during leishma- 
nial  infection,  in  which  only the  pathway(s)  common to 
IL-12(p40) induction might be impaired. 
Selective inhibition of IL-12 synthesis was also  observed 
when  BMMo  were  treated  with  IFN-%  which  revealed 
that  the  parasite  could  provide  a  detectable  stimulus  for 
TNF-ix and iNOS gene expression in primed cells, but still 
failed to provide a trigger for IL-12. In contrast,  exposure 
of the  cells  to  LPS,  killed Mtb,  or  STAg during priming 
with  IFN-',/ resulted  in  significantly upregulated  synthesis 
of TNF-o~,  iNOS,  and  especially  IL-12.  The  ability  of 
Leishmania-infected  cells  to be activated by IFN-~ for in- 
tracellular  killing,  either  alone  or  in  combination  with 
other stimuli, is well described (1, 2, 29).  The data suggest 
that the inability of the parasite to induce certain cytokines 
during infection is due less to the fact that relevant induc- 
tion pathways are disrupted than to the fact that the parasite 
alone is unable to provide both the priming and triggering 
stimuli  required  for  their  expression.  Other  investigators 
have reported that even primary exposure of macrophages 
to Leishmania,  either amastigotes or promastigotes, results in 
release of significant levels of IL-1 or TNF-o~ (27,  29,  39, 
40). It is not clear why in our studies and that of others (41) 
the  parasite  alone  failed  to  stimulate  production  of these 
cytokines, although differences in the subpopulation of the 
macrophages used and/or  LPS contamination  are  possible 
explanations.  These  data,  nonetheless,  reinforce  the  con- 
clusion that Leishmania-infected  cells retain the potential to 
produce  most  of the  cytokines  involved in  inflammatory 
and effector functions, including those mediated by IFN-~/. 
The reciprocal effects that the parasite has on IL-12 and 
IL-10 production by BMMo does not seem to explain the 
preferential activation of Th2  cells  during infection of ge- 
netically  susceptible  BALB/c  mice,  since  identical  out- 
comes were observed using BMMo from resistant C57BL/6 
and C3H mice. In addition, these effects were not confined 
to  Leishmania  species  with  particular  clinical  associations, 
since  they were  seen using both  L.  major and  L.  donovani 
promastigotes.  The  avoidance  of IFN-~  induction  path- 
ways might, instead,  underlie  the  relatively prolonged du- 
ration of parasite survival and amplification that  is charac- 
teristic of leishmanial infections generally, whether they be 
self-healing  or  progressive,  cutaneous  or  visceral.  Unlike 
the rapidly self-limiting infections produced by other intra- 
cellular pathogens,  such as Mycobacteria,  Listeria,  Cryptospo- 
ridia,  or  Toxoplasma,  the  self-limiting infections  caused by 
Leishmania  require weeks or months to resolve. Leishmania 
strains able to amplify their numbers by delaying the onset 
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transmission.  This may be especially true for parasites  pro- 
ducing localized cutaneous or mucosal disease,  which will 
have infrequent encounters with their phlebotomine vectors. 
There is considerable evidence that the delayed onset of 
heating typically seen in self-limiting forms of leishmanial 
disease  is  due  to  the  slow  development of cell-mediated 
immune  response  (i.e.,  delayed  production  of  IFN-~), 
rather than,  as has been suggested (42),  the inability of in- 
fected cells  to  be  activated for killing  (that is,  impaired 
response to  IFN-~/).  For example, patients  are susceptible 
to reinfection during the active stages of cutaneous disease, 
whereas they are resistant after healing has commenced (43, 
44,  and  reviewed in  reference 45).  Experimentally,  evi- 
dence for defective IL-12 induction by Leishmania is sug- 
gested by studies in scicl  mice, which are capable of produc- 
ing a T  cell-independent, IL-12-dependent IFN-~/response 
to a variety of intracellular bacteria and parasites,  including 
L.  monocytogenes, Corynebacterium parvum, Salmonella, Myco- 
bacteria, and  T. gondii (12,  25,  46).  In contrast, L.  donovani 
promastigotes failed to initiate an NK cell-derived IFN-~/ 
response in spleen ceils from scid mice, either in vivo or in 
vitro (47). 
Direct  evidence  for  delayed  induction  of  IL-12(p40) 
transcripts  during L. major  infection was reported by Reiner 
et al.  (15) for both susceptible and resistant mouse strains). 
In addition, anti-IL-12 antibodies could be administered to 
C57BL/6 mice as late as 2 wk after infection and still exac- 
erbate disease,  consistent with delayed production of IL-  12 
(48). In more recent studies (49, 50), delayed production of 
IL-12  in  response  to  L.  major was  confined to  C57BL/6 
mice, whereas C3H and, surprisingly, BALB/c mice, pro- 
duced an elevated IL-12 response within  1 d  of infection. 
Whereas the early C3H response was associated with rapid 
control of the parasite,  the delayed response in  C57BL/6 
mice was associated with larger lesions requiring longer to 
heal. For BALB/c mice, the induction of Thl cells and el- 
evated levels of IFN-~/ by IL-12  was  thought to  be pre- 
vented by the  simultaneous  production  of inhibitory cy- 
tokines. 
To what extent do the in vitro outcomes using BMMo 
grown in M-CSF conditioned medium and used after 6-7 d 
of  adherence,  which  represent  relatively  heterogeneous 
populations of differentiated cells, reflect the in vivo expe- 
rience with high doses of subcutaneously inoculated para- 
sites? The response of  BMMo to infection is certainly con- 
sistent with the in vivo outcomes in C57BL/6 mice, which 
arguably model most closely the course of cutaneous leish- 
maniasis  in  natural  hosts.  In  contrast,  the  early IL-12  re- 
sponse in C3H and BALB/c mice might be explained by 
strain polymorphisms in the number and tissue  distribution 
of distinct macrophage subpopulations, or cell types such as 
B  cells, keratinocytes or neutrophils, that are each capable 
of producing IL-12,  but  that  might  respond  quite  differ- 
ently to  the parasite  or its  products.  Recent  observations 
bear indirectly  on  this  point.  When  leishmanial  antigens 
were presented by GM-CSF-derived macrophages as  op- 
posed to  M-CSF  macrophages,  they were able  to  induce 
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high levels of IFN-3' and resistance to infection in BALB/c 
mice (51).  There is growing evidence from in vitro studies 
that differences in antigen-presenting cell  populations can 
influence  the  pattern  of CD4 +  subset  development (52). 
The ability of a high dose inoculum to stimulate an early 
IL-12 response in certain mouse strains  may reflect events 
which  are  more  typically  delayed  during  infection  in 
C57BL/6 mice and natural hosts. As  the parasite load in- 
creases, the parasite or its products might no longer be con- 
fined to the same cell types targeted by metacyclic promas- 
tigotes  at  the  initiation  of infection,  such  that  different 
patterns of regulatory cytokines emerge. 
Although IL-10 was first described as a cytokine that in- 
hibits  macrophage-dependent  cytokine  synthesis  by  Thl 
cells  (30),  it does not appear to be involved in downregu- 
lating IL-12 synthesis by infected macrophages since  cells 
from IL-10 knockout mice still failed to produce IL-12 in 
response to promastigotes, and were also  markedly inhib- 
ited  by  the  parasite  for  expression  of LPS-  and  Mtb- 
induced  IL-12(p40)  transcripts  and  protein.  It  is  possible 
that IL-10 production by infected cells might impair other 
accessory cell functions. IL-10 has been found to downreg- 
ulate expression of  B7 and other costimulatory surface mol- 
ecules (53), and this might be related to the recent observa- 
tion that B7 is downregulated on Leishmania-infected  cells 
(54).  Furthermore, since B7/CD28  interactions synergize 
with IL-12 to induce high levels ofIFN-~/(55, 56), the co- 
ordinate inhibition of both molecules, whether by related 
or independent mechanisms, might ensure that IFN-~/ in- 
duction pathways are avoided. The previously unreported 
possibility that the parasite can directly activate an IL-10 re- 
sponse in macrophages, might explain the source of IL-10, 
which has been found to be associated with certain chronic 
leishmanial infections (57,  58), especially since other Th2- 
associated cytokines were not also seen. 
The possible  role  of TGF-[3 in  IL-12  downregulation 
has  not  been  investigated in  these  studies  but  should  be 
considered, given the ability of this mediator to potentiate 
Leishmania intramacrophage  survival in  vitro and  in  vivo 
(59,  60).  TGF-[3 is  a  suppressor of many known  macro- 
phage responses, including the oxidative burst (61),  micro- 
bicidal response to  IFN-~/  (59),  as well as  IL-12-initiated 
IFN-~/production by human neonatal CD4 + cells (62).  Its 
pleiotropic activities may not, therefore, be consistent with 
the selective effects that the parasite has on IL-12. Further- 
more, TGF-[3-mediated suppression  ofLPS-induced TNF-e~ 
and IL-1 release by macrophages was found to be late act- 
ing (12-16 h; 63); this is not consistent with the defects as- 
sociated with IL-12(p40) induction in infected cells. 
The alternative to agonist-mediated suppression of IL-12 
induction is that the parasite or its products directly inter- 
fere with specific signal-transducing events.  There is sub- 
stantial evidence that leishmanial infection selectively impairs 
PKC-dependent  signal  transduction  in  host  macrophages 
(64,  65),  suggesting that this may be an essential  pathway 
for induction  of IL-12.  Leishmania-infected  cells  or mac- 
rophages treated with promastigote LPG display defective 
membrane translocation of PKC or defective phosphoryla- tion of endogenous PKC substrates, respectively. It is clear 
that since the LPG-deficient mutant, R2D2,  was as inhibi- 
tory for IL-12 induction as the wild-type strain, LPG is not 
required for  this  effect.  This  result does  not  rule  out  the 
possible role  of LPG-related structures,  that  is, the  glyco- 
sylinositolphospholipids (66), which are still abundantly ex- 
pressed  by  R2D2.  The  involvement  of PKC-dependent 
signal  transduction  in  IL-12  upregulation  and  its  specific 
disruption by the parasite are currently being explored. 
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